Sean F. Scanlan is VP at TREACE MEDICAL CONCEPTS, INC. (TMCI). They have made 9 open-market trades across 1 company since 2021, most recently 2026-08-09.
CIK 0001856371
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TMCI | 679,863 | $2.6M |
Shares reported on the most recent Form 4, priced at the 2026-08-12 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TMCI | SELL · 10b5-1 | 2025-03-17 | 2025-03-19 | $7.97 | $399K | +4.0% | -20.2% | -32.6% |
| TMCI | SELL | 2023-05-16 | 2023-05-18 | $25.44 | $636K | -0.2% | -3.0% | -36.7% |
| TMCI | SELL | 2023-03-09 | 2023-03-10 | $24.41 | $12K | +0.3% | +15.6% | +9.2% |
| TMCI | SELL | 2023-02-15 | 2023-02-17 | $21.69 | $542K | -6.3% | +7.8% | +20.9% |
| TMCI | SELL | 2023-01-12 | 2023-01-13 | $25.57 | $639K | -2.7% | -17.8% | -0.1% |
| TMCI | SELL | 2022-11-14 | 2022-11-16 | $24.27 | $607K | +7.2% | +11.2% | +4.1% |
| TMCI | SELL | 2022-03-02 | 2022-03-04 | $20.82 | $521K | -6.3% | -6.1% | -17.5% |
| TMCI | SELL | 2022-02-08 | 2022-02-10 | $20.04 | $1.0M | -9.3% | -15.7% | -38.4% |
| TMCI | SELL | 2022-01-10 | 2022-01-12 | $20.15 | $1.9M | -12.2% | +0.1% | -3.9% |
| TMCI | SELL · 10b5-1 | 2022-01-03 | 2022-01-05 | $20.02 | $46K | +6.3% | +3.4% | +7.4% |
| TMCI | SELL | 2021-11-10 | 2021-11-12 | $21.54 | $1.1M | -17.3% | -19.3% | -2.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.